Neoplasms, Colorectal Terminated Phase 2 Trials for Nintedanib (DB09079)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02780700Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]Treatment